Official Journal of Research Center for Gastroenterology and Liver Diseases
CrossRef
Works that cite this article, indexed by Crossref.
Ombitasvir: a potent pan-genotypic inhibitor of NS5A for the treatment of hepatitis C virus infection
Expert Review of Anti-infective Therapy 12(9) (2014)
Ivan Gentile; Antonio Riccardo Buonomo; Guglielmo Borgia
Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus
Expert Opinion on Investigational Drugs 23(9) (2014)
Ivan Gentile; Nicola Coppola; Antonio Riccardo Buonomo; Emanuela Zappulo; Guglielmo Borgia
New direct-acting antivirals in hepatitis C therapy: a review of sofosbuvir, ledipasvir, daclatasvir, simeprevir, paritaprevir, ombitasvir and dasabuvir
Expert Review of Clinical Pharmacology 9(2) (2016)
Sean M. McConachie; Sheila M. Wilhelm; Pramodini B. Kale-Pradhan
MK-5172: a second-generation protease inhibitor for the treatment of hepatitis C virus infection
Expert Opinion on Investigational Drugs 23(5) (2014)
Ivan Gentile; Antonio Riccardo Buonomo; Federico Borgia; Emanuela Zappulo; Giuseppe Castaldo; Guglielmo Borgia
Investigational direct-acting antivirals in hepatitis C treatment: the latest drugs in clinical development
Expert Opinion on Investigational Drugs 25(5) (2016)
Ivan Gentile; Riccardo Scotto; Emanuela Zappulo; Antonio Riccardo Buonomo; Biagio Pinchera; Guglielmo Borgia
Anti-HBc positivity was associated with histological cirrhosis in patients with chronic hepatitis C
Annals of Hepatology 13(1) (2014)
Nicola Coppola; Ivan Gentile; Giuseppe Pasquale; Antonio Riccardo Buonomo; Nicolina Capoluongo; Maria D’Armiento; Guglielmo Borgia; Evangelista Sagnelli
The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C
Expert Opinion on Drug Discovery 10(12) (2015)
Ivan Gentile; Alberto Enrico Maraolo; Antonio Riccardo Buonomo; Emanuela Zappulo; Guglielmo Borgia
Noninvasive scoring algorithm to identify significant liver fibrosis among treatment-naive chronic hepatitis C patients
European Journal of Gastroenterology & Hepatology 26(10) (2014)
Tomas Koller; Jana Kollerova; Martin Huorka; Iveta Meciarova; Juraj Payer
Development and Validation of a Noninvasive Risk Score Model for Liver Cirrhosis in At-Risk Alcohol Drinkers Without HBV/HCV Infection
Cancer Prevention Research 15(11) (2022)
Yin Liu; Lan-Wei Guo; Hui-Fang Xu; Rui-Hua Kang; Li-Yang Zheng; Lu-Yao Zhang; Qiong Chen; Xi-Bin Sun; You-Lin Qiao; Shao-Kai Zhang
Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world?
Expert Review of Anti-infective Therapy 12(7) (2014)
Ivan Gentile; Antonio Riccardo Buonomo; Emanuela Zappulo; Guglielmo Borgia
Risk of Liver Cirrhosis in At-Risk Alcohol Drinkers Without HBV/HCV Infection: Development and Validation of a Simple Non-Invasive Risk Score Model
SSRN Electronic Journal (2021)
Yin Liu; Lan-wei Guo; Hui-fang Xu; Rui-hua Kang; Li-yang Zheng; Lu-yao Zhang; Qiong Chen; Xi-bin Sun; Shao-kai Zhang; You-Lin Qiao
Ledipasvir: a novel synthetic antiviral for the treatment of HCV infection
Expert Opinion on Investigational Drugs 23(4) (2014)
Ivan Gentile; Antonio Riccardo Buonomo; Federico Borgia; Giuseppe Castaldo; Guglielmo Borgia
Risk of Liver Cirrhosis in HBV/HCV-Infected Individuals with First-Degree Relatives Who Have Liver Cancer: Development and Validation of a Simple Model
Cancer Prevention Research 15(2) (2022)
Yin Liu; Lan-Wei Guo; Hui-Fang Xu; Rui-Hua Kang; Li-Yang Zheng; Lu-Yao Zhang; Qiong Chen; Xi-Bin Sun; Shao-Kai Zhang; You-Lin Qiao
Current drugs in early development for treating hepatitis C virus-related hepatic fibrosis
Expert Opinion on Investigational Drugs 24(9) (2015)
Jerzy Jaroszewicz; Marta Flisiak-Jackiewicz; Dariusz Lebensztejn; Robert Flisiak
Beclabuvir for the treatment of hepatitis C
Expert Opinion on Investigational Drugs 24(8) (2015)
Ivan Gentile; Emanuela Zappulo; Antonio Riccardo Buonomo; Alberto Enrico Maraolo; Guglielmo Borgia
GS-9669: a novel non-nucleoside inhibitor of viral polymerase for the treatment of hepatitis C virus infection
Expert Review of Anti-infective Therapy 12(10) (2014)
Ivan Gentile; Antonio Riccardo Buonomo; Emanuela Zappulo; Nicola Coppola; Guglielmo Borgia
Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus
Expert Review of Anti-infective Therapy 12(7) (2014)
Ivan Gentile; Emanuela Zappulo; Antonio Riccardo Buonomo; Guglielmo Borgia
Ferritin and liver fibrosis among patients with chronic hepatitis C virus infection
Journal of Trace Elements in Medicine and Biology 61 (2020)
Candelaria Martín-González; Ricardo Pelazas-González; Camino Fernández-Rodríguez; Remedios Alemán-Valls; Antonio Martínez-Riera; Paula Ortega-Toledo; Alen García-Rodríguez; Melchor Rodríguez-Gaspar; Emilio González-Reimers